Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
711
-
Total 13F shares, excl. options
-
81.3M
-
Shares change
-
+816K
-
Total reported value, excl. options
-
$16.1B
-
Value change
-
+$226M
-
Put/Call ratio
-
1.64
-
Number of buys
-
367
-
Number of sells
-
-268
-
Price
-
$198.03
Significant Holders of RESMED INC - Common Stock (RMD) as of Q1 2024
810 filings reported holding RMD - RESMED INC - Common Stock as of Q1 2024.
RESMED INC - Common Stock (RMD) has 711 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.3M shares
of 146M outstanding shares and own 55.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (17.8M shares), BlackRock Inc. (12.2M shares), STATE STREET CORP (6.3M shares), Bank of New York Mellon Corp (3.81M shares), GEODE CAPITAL MANAGEMENT, LLC (3.42M shares), MORGAN STANLEY (1.94M shares), Invesco Ltd. (1.87M shares), FMR LLC (1.61M shares), NORGES BANK (1.52M shares), and NORTHERN TRUST CORP (1.42M shares).
This table shows the top 711 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.